Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
By exploring the feasibility, effectiveness and safety of neoadjuvant therapy with Sintilimab
combined with platinum-containing chemotherapy in patients with resectable Stage ⅡB-ⅢA NSCLC,
we will provide new treatment options and strategies for stage ⅡB-ⅢA NSCLC.
Phase:
Phase 2
Details
Lead Sponsor:
The Second Affiliated Hospital of Shandong First Medical University